Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Pneumonia
Epidemiology
Leading cause of death globally among children
younger than age 5 yrs.
Higher incidence in developing countries.
In the Philippines, a study of children below 5 years old
with pneumonia confirmed the burden of invasive
pneumococcal disease which ranged from 25-35 per
100,000 population. (2009-2010)
WHO: 50% of deaths due to pneumonia in children 5
years old and below are due to S. pneumoniae
infections. H. influenza infections account for 20% of
deaths (serotypes 6, 18, 14 most prevalent).
Etiology
Most cases caused by microorganisms
Noninfectious causes: aspiration, hypersensitivity
reaction, drug- or radiation induced pneumonitis.
Streptococcus pneumoniae: most common bacterial
pathogen in children 3wk-4yr of age.
Mycoplasma pneumoniae & Chlamydophila
pneumonaie: most frequent bacterial pathogens in age
5yr and older.
Other bacterial causes: Group A Strep (S. pyogenes) and
S. aureus (complicates an infection caused by influenza
viruses)
Etiology
S. pneumoniae, H. influenza and S. aureus: major causes of
hospitalization and death from bacterial pneumoniae
M. tuberculosis, Salmonella, E. coli and P. jiroveci: causes of
pneumonia in HIV infected children.
Viral pathogens: prominent cause of LRT infections in infants
and children older than 1 month but younger than 5 yrs.
RSV and rhinoviruses are the most commonly identified
pathogens especially in children younger than 2yrs.
Other common viruses: influenza virus, parainfluenza,
adenovirus, enterovirus, and human metapneumovirus.
AGE GROUP
Neonates (<3wk)
3wk-3mo
4mo-4yr
Pathogenesis
Normal physiologic barriers include the mucociliary
clearance, secreatory immunoglobulin in sectretions
and clearing of airway by coughing.
Immunologic defense mechanisms of the lung include
macrophages that are present in alveoli and
bronchioles, secretory IgA.
Trauma, anesthesia, and aspiration increases the risk of
pulmonary infection.
Recurrent Pneumonia
Defined as 2 or more episodes in a single year or
3 or more episodes ever, with radiographic clearing
between occurences.
Clinical Manifestations
Preceded by several days of symptoms of an URTI,
usually rhinitis and cough.
Fever
Tachypnea: most consistent manifestation of
pneumonia
Increased work of breathing with intercostal, subcostal
and suprasternal retractions, use of accessory muscles,
nasal flaring.
Cyanosis and lethargy in severe infection.
Crackles and wheezing upon auscultation.
Physical Findings
Diminished breath sounds, scattered crackles, and
rhonchi over the affected lung feilds.
Dullness noted on percussion with increasing
consolidation.
Lag in respiratory excursion often on the affected side
Abdominal distention prominent due to gastric dilations
from swallowed air or ileus.
Abdominal pain common in lower-lobe pneumonia
Liver may seem enlarged due to downward
displacement of the diaphragm secondary to
hyperinflation of the lungs.
Findings in Infants
Prodrome of URTI and diminished appetite,, leading to
abrupt onset of fever, restlessness, apprehension, and
respi distress.
Appear ill with respiratory distress manifested as
grunting; nasal flaring; retractions of the
supraclavicular, intercostal, and subcostal area;
tachypnea; tachycardia; air hunger and often cyanosis.
Associated GI disturbances characterized by vomiting,
anorexia, diarrhea and abdominal distention secondary
to paralytic ileus.
Diagnosis
Chest Rdiograph (PA and lateral views) shows
infiltrates.
Indicates complications: pleural effusion or empyema
Viral pneumonia: hyperinflation with bilateral interstitial
infiltrates and peribronchial cuffing
Pneumococcal pneumonia: confluent lobar consolidation
Radiographic appearance alone is not diagnostic, other clinical
features must be considered.
Diagnosis
Handheld ultrasonography is highly sensitive and
specific in diagnosis pneumonia in children by
determining lung consolidations and air bronchograms
or effusions.
WBC count:
may be normal in viral pneumonia, if elevated it is not higher
than 20,000/mm3 with lymphocyte predominance
Bacterial pneumonia associated with elevated WBC in the
range of 15,000-40,000/mm3 and a predominance of
granulocytes.
Different
ial
Diagnosi
s
Treatment
Penicillin G is the parenteral drug of choice for infections
caused by penicillin-susceptible strains of S.
pneumoniae. Dosage ranging from 50,00-300,000
units/kg/day for minor infections and sever infections
such as meningitis.
Macrolides and cephalosporins are alternative treatment
for penicillin-allergic patients.
Critical time for treatment is during the first few hours
after the initial patient evaluation before cultures are
available.
S. pneumoniae is resistant to cotrimoxazole, penicillin,
chloramphenicol and erythromycin.
Prognosis
patients with uncomplicated community-acquired bacterial
pneumonia show response to therapy, with improvement in
clinical symptoms (fever, cough, tachypnea, chest pain), within
48-96 hr of initiation of antibiotics.
patient does not improve with appropriate antibiotic therapy:
emphysema
Bacterial resistance
Viral or Foreign body aspiration
Bronchial obstruction
Preexisting condition such as immunodeficiency, ciliary dyskinesia, cystic fibrosis,
pulmonary sequestration, or cystic adenomatoid malformation
Compliactions
Complications of pneumonia are usually the result of
direct spread of bacterial infection within the thoracic
cavity (pleural effusion, empyema, pericarditis) or
bacteremia and hematologic spread.
Meningitis, suppurative arthritis, and osteomyelitis are
rare complications of hematologic spread of
pneumococcal or H. influenzae type b infection.
S. aureus, S. pneumoniae, and S. pyogenes are the
most common causes of parapneumonic effusions and
of empyema.
Prevention
vaccination has reduced the incidence of pneumonia
hospitalizations.
7-valent pneumococcal conjugate vaccine (PCV7) and
currently the 13-valent pneumococcal conjugate
vaccine (PCV13) is licensed.
influenza vaccine recommendations to include all
children >6 mo of age.
IMCI Booklet